文献速递神经肿瘤

合成Epsin模拟肽在胶质瘤模型中的治疗效力:揭示VEGF相关肿瘤血管生成之外的多种机制

Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis.
PubMed 文献 · J Neurooncol · 2018-01-22

该研究在GL261胶质瘤模型中测试化学合成肽UPI竞争性抑制Epsin与VEGFR2结合的治疗效力与靶向特异性。UPI治疗显著抑制并缩小肿瘤生长,特异性靶向VEGFR2信号通路,长期给药导致肿瘤血管严重血栓形成并损伤肿瘤细胞,且意外靶向癌细胞诱导凋亡。作者认为UPI肽通过特异性靶向肿瘤血管和癌细胞中的VEGFR2信号,是胶质瘤生长的强效抑制剂,可能为对当前抗VEGF治疗耐药的患者提供潜在新疗法。

要点

  • UPI肽在GL261胶质瘤模型中显著抑制并缩小肿瘤生长。
  • UPI肽通过遗传和生化方法证实特异性靶向VEGFR2信号通路。
  • 长期UPI给药导致肿瘤血管严重血栓形成并损伤肿瘤细胞,且意外靶向癌细胞诱导凋亡。

核心结论

  • UPI肽通过特异性靶向肿瘤血管和癌细胞中的VEGFR2信号,是胶质瘤肿瘤生长的强效抑制剂,可能为对当前抗VEGF治疗耐药的患者提供潜在新疗法。

研究设计与样本

  • 在GL261胶质瘤肿瘤模型中进行UPI肽治疗效力与靶向特异性测试的动物实验研究。

主要发现

  • UPI治疗显著抑制并缩小GL261胶质瘤模型中的肿瘤生长。
  • UPI肽经遗传和生化方法证实特异性靶向VEGFR2信号通路。
  • 长期UPI肽给药导致肿瘤血管严重血栓形成并损伤肿瘤细胞。
  • UPI肽意外靶向癌细胞并诱导凋亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Binding of epsin ubiquitin-interacting motif (UIM) with ubiquitylated VEGFR2 is a critical mechanism for epsin-dependent VEGFR2 endocytosis and physiological angiogenesis. Deletion of epsins in vessel endothelium produces uncontrolled tumor angiogenesis and retards tumor growth in animal models. The aim of this study is to test the therapeutic efficacy and targeting specificity of a chemically-synthesized peptide, UPI, which compete for epsin binding sites in VEGFR2 and potentially inhibits Epsin-VEGFR2 interaction in vivo, in an attempt to reproduce an epsin-deficient phenotype in tumor angiogenesis. Our data show that UPI treatment significantly inhibits and shrinks tumor growth in GL261 glioma tumor model. UPI peptide specifically targets VEGFR2 signaling pathway revealed by genetic and biochemical approaches. Furthermore, we demonstrated that UPI peptide treatment caused serious thrombosis in tumor vessels and damages tumor cells after a long-term UPI peptide administration. Besides, we revealed that UPI peptides were unexpectedly targeted cancer cells and induced apoptosis. We conclude that UPI peptide is a potent inhibitor to glioma tumor growth through specific targeting of VEGFR2 signaling in the tumor vasculature and cancer cells, which may offer a potentially novel treatment for cancer patients who are resistant to current anti-VEGF therapies.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Dong J, Saunders D, Silasi-Mansat R, et al. Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis. J Neurooncol. 2018. PMID: 29357089. doi:10.1007/s11060-018-2766-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。